Abstract:Abstract Background Little study investigates the association between baseline type 2 biomarker levels and clinical features in children diagnosed with asthma. Characterizing clinical remission in Th2-high asthma could offer valuable insights into asthma prognosis. Objectives The study aims to investigate the association of baseline type 2 biomarker levels and clinical features in children with asthma, and to identify predictors of clinical remission of asthma in children. Methods A total of 172 children with baseline age of 6.87 ± 3.04 (mean ± SD) years were enrolled in the study including 119 with physician-diagnosed asthma who regularly attended a pediatric asthma center and 53 control subjects with no respiratory symptoms. Clinical tests included lung function examination, Fraction of exhaled NO (FeNO), total IgE, blood eosinophil, and skin test. Serum Th2 biomarkers were examined by ELISA. The enrolled patients have readjusted into Th2-high asthma according to clinical eosinophil count and total IgE, and Th2-high asthma subjects were further classified into acute attack asthma, persistent asthma, and clinical remission according to the recent GINA guidelines and clinical evaluation. To verify our results, the concentration of TSLP levels was measured in BALF, serum, and lung tissue by ELISA in mouse models. Results Compared with asthma and control groups, eosinophil counts and blood eosinophils (%) were significant, whereas, no correlation was observed between asthma subjects and controls including Th2 biomarkers, gender, or ages. Positive correlations were observed between Th2 inflammatory biomarkers (TSLP, TRAC IL-5, IL-13, and Periostin) at baseline. Th2-high asthma (n = 110) was defined based on clinical measurement of IgE > 100 IU/ml and a blood eosinophil count ≥ 140 cells/µl. Among those Th2-high asthma subjects, there were 48 in acute exacerbation (43.6%), and 36 in clinical remission (32.7%), 26 were clinical asthma persistence (23.6%). Lung function and serum TSLP had marked significance among the three categories. Compared with clinical remission asthmatic subjects and controls, serum TSLP levels were significantly higher in subjects experiencing acute exacerbation and subjects defined as asthma persistence. Spearman’s correlation outlined that serum TSLP levels were related to Total IgE (IU/mL), FEV1/FVC ratio, and FEF25-75, pred %. Multivariate logistic regression analysis demonstrated that serum TSLP levels were associated with clinical remission in Th2-high asthma children (OR = 1.009; 95% CI, 1.0087–1.0086 P = 0.023<0.05). It is also revealed that serum TSLP levels may help evaluate clinical remission in Th2-high asthma when using ROC curves analysis (AUC = 0.5887, 95% CI: 0.5052 to 0.7038, P < 0.05). A cutoff value of 373.363 pg/mL was found with the highest clinical sensitivity and specificity. PPV, and NPV were 100%, 39.1%, and 59.4%, 100% in two groups, respectively. However, there were no positive results in the analysis of multivariable logistic regression in determining the predictors of persistence in Th2-high asthma. In BALF mouse, TSLP concentration had no statistically significant change in the acute and remission stages when compared to the control, but it did increase noticeably in the chronic stage (P < 0.001).

Thymus vulgaris ameliorates cough in children with asthma exacerbation: a randomized, triple-blind, placebo-controlled clinical trial

Activity study of the ethanol extract of thunberg fritillary leaf and the ethanol extract of thunberg fritillary flower on relieving cough, abolishing phlegm and relieving asthma

Clinical significance of FEV0.5 and FEV0.75 in the determination of pulmonary function in children with bronchial asthma

Airway Inflammation, Bronchial Hyperresponsiveness, and Anti-Asthma Therapy Responses in Cough Variant Asthma and Classic Asthma with FEV1%≥80% Predicted

Therapeutic effect of ambroxol hydrochloride on children with cough variant asthma

[Astragalus Granule Combined Auricular Point Sticking for Cough Variant Asthma in Children]

Latent myofascial trigger points injection therapy for adult cough variant asthma: A randomized controlled trial

Treatment efficacy evaluation of standardized management for children with asthma

Clinical efficacy and safety of fluticasone/salmeterol inhalation powder combined with huaiqihuang granules in the treatment of children with cough variant asthma

Effect of Plantago major on cough severity in acute bronchitis: A double-blind randomized clinical trial

Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma

Prescriptions from Traditional Chinese Medicine Compared with Salbutamol and Montelukast for the Treatment of Pediatric Asthma: a Randomized Controlled Trial

Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: A meta‐analysis

Clinical Observation and Mechanism Study on the Treatment of Cough Variant Asthma in Children by Soufeng Xiaoanyu Prescription

The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma

Baseline Type 2 Biomarker Levels and Clinical Remission Predictors in Children with Asthma

A 12 week double-blind randomised controlled trial investigating the effect of dietary supplementation with 5000 IU/day (125 μg/day) vitamin D in adults with asthma, led to an improvement in the lung function parameter - FEV1:FVC ratio

Efficacy of vitamin D supplementation in asthmatic children with vitamin D deficiency: A randomized controlled trial (ESDAC trial)

Efficacy of Breathing Training for Asthmatic Bronchitis in Children

Immunomodulatory effects of Thymol through modulation of redox status and trace element content in experimental model of asthma

Regulatory T Cells and Th1/Th2 in Peripheral Blood and Their Roles in Asthmatic Children.